Strong, but Age-Dependent, Protection Elicited by a Deoxyribonucleic Acid/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine

Background. In this study, we analyzed the protective efficacy of a simian immunodeficiency virus (SIV) macaque 239 (SIVmac239) analogue of the clinically tested GOVX-B11 deoxyribonucleic acid (DNA)/modified vaccinia Ankara (MVA) human immunodeficiency virus vaccine. Methods. The tested vaccine used...

Descripción completa

Detalles Bibliográficos
Autores principales: Chamcha, Venkateswarlu, Kannanganat, Sunil, Gangadhara, Sailaja, Nabi, Rafiq, Kozlowski, Pamela A., Montefiori, David C., LaBranche, Celia C., Wrammert, Jens, Keele, Brandon F., Balachandran, Harikrishnan, Sahu, Sujata, Lifton, Michelle, Santra, Sampa, Basu, Rahul, Moss, Bernard, Robinson, Harriet L., Amara, Rama Rao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800464/
https://www.ncbi.nlm.nih.gov/pubmed/27006959
http://dx.doi.org/10.1093/ofid/ofw034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800464/
https://www.ncbi.nlm.nih.gov/pubmed/27006959
http://dx.doi.org/10.1093/ofid/ofw034

Ejemplares similares